News
A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...
10h
Cyprus Mail on MSNFrom $0.03 to $1: Could Mutuum Finance (MUTM)’s next leg outpace Shiba Inu (SHIB)’s 2021 meteoric run?Shiba Inu (SHIB) captured the world’s attention in 2021 with its outrageous surge. When a meme-inspired token turns into a market sensation, investors dream of the next rocket. Today, Mutuum Finance ...
UN seeks $46 million to aid 2 million Haitians facing hunger as gang violence displaces over 1 million people.
Splitgate 2 has now officially released, leaving its open beta phase and fully launching on PS5 today, 6th June 2025. A ...
If you recall, portions of the Southwest Freeway will be extended over the Brazos River as it has begun to erode the land underneath it.
Abstract Title: Rationale and Study Design for a Phase 2/3, Double-blinded, Randomized, Dose-repeating, Cross-over Study to ...
The novel selective antibody sibeprenlimab reduced proteinuria more than any prior drug for IgA nephropathy, with excellent ...
In May, the FDA granted significant drug approvals across various therapeutic areas, marking notable progress in expanding treatment options for patients.
The Genshin Impact 5.7 Banner and event details have officially been announced for the latest patch, which is titled A Space ...
SBI Securities maintains a 'Buy' rating on Hi-Tech Pipes Ltd with a target price of ₹138, indicating a 43.4% upside. The ...
A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...
BDC-4182 Phase 1 dose-escalation study now open for enrollmentBDC-3042 Phase 1 dose-escalation data presented at AACR 2025 demonstrated a favorable safety profile, dose-dependent biological activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results